138660-99-8 imciromab pentetate
| ?? ????? |
imciromab pentetate |
| ?????? |
Imciromab Pentetate [USAN:BAN]; Imciromab pentetate; ? 4; C-4 (?????); ?????????????? G 2a (?? ??-???? ???? R11D10 ???? Fab ????? ???? ?? ?????? ?? ????-?????), ???????? ?? ????? ???? ?? ??-???? R11D10 ?? ????, N,N-bis(2-(bis(carboxymethyl)amino)????)?????? ?????; ?????????????? G 2a (?? R11D10 ?? ???? ???? ???? Fab ????? ???? ?????? ?? ????-?????), ???????? ?? ???? ??-???? R11D10 ?? ????-?????, N,N-bis(2-(bis(carboxymethyl)amino)????)?????? ?????.????? ????????? ??? ?-50,000 ?????; ??????? |
| ?? ????? |
imciromab pentetate;Imciromab Pentetate [USAN:BAN]; Imciromab pentetate; C 4; C-4 (drug); Immunoglobulin G 2a (mouse monoclonal R11D10 cell Fab fragment anti-human cardiac myosin heavy chain), disulfide with mouse monoclonal R11D10 cell kappa-chain, N,N-bis(2-(bis(carboxymethyl)amino)ethyl)glycine conjugate; Immunoglobulin G 2a (mouse monoclonal R11D10 cell Fab fragment anti-human cardiac myosin heavy chain), disulfide with mouse monoclonal R11D10 cell kappa-chain, N,N-bis(2-(bis(carboxymethyl)amino)ethyl)glycine conjugate. Molecular weight is approximately 50,000 daltons; Myoscint |
| ???? CAS |
138660-99-8 |
|
IL
CN
CZ
DE
EN
ES
FR
GR
HU
ID
IN
IR
IT
JP
KR
MY
NL
NO
PL
PT
RU
SA
TR
